Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study. (Record no. 30153088)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01469 a2200421 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518062444.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 202009s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1097-6787 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.jaad.2019.09.036 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Soria, Angèle |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20200911 |
245 00 - TITLE STATEMENT | |
Title | Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of the American Academy of Dermatology |
Date of publication, distribution, etc. | Mar 2020 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 606-611 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Allopurinol |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Bacterial Agents |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Contrast Media |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Hypersensitivity Syndrome |
General subdivision | diagnosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | France |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Retrospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfasalazine |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bernier, Claire |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Veyrac, Gwenaelle |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Barbaud, Annick |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Puymirat, Etienne |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Milpied, Brigitte |
773 0# - HOST ITEM ENTRY | |
Title | Journal of the American Academy of Dermatology |
Related parts | vol. 82 |
-- | no. 3 |
-- | p. 606-611 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.jaad.2019.09.036">https://doi.org/10.1016/j.jaad.2019.09.036</a> |
Public note | Available from publisher's website |
No items available.